2021 Medicinal Chemistry Reviews
Recent Advances in Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors
Chris Limberakis, David W. Piotrowski
Ref. n°: REV2021-ch4
You must be connected to be able to download the pdf file of this chapter.